Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000008

Chief Discovery Officer sold 45,422 shares at an average $29.66 ($1,347,066)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kreitzer Anatol Chief Discovery Officer 2026-04-27 Sale 10b5-1 −8,346 $28.96 $241,700 248,266 D: show line 1 in the form
Kreitzer Anatol Chief Discovery Officer 2026-04-27 Sale 10b5-1 −29,255 $29.63 $866,826 219,011 D: show line 2 in the form
Kreitzer Anatol Chief Discovery Officer 2026-04-27 Sale 10b5-1 −7,821 $30.50 $238,541 211,190 D: show line 3 in the form
Open-market sales · 45,422 sh · avg $29.66 · $1,347,066
Loading xslF345X06/form4-04292026_040429.xml…